David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Comcast
CMCSA
|
+$354M |
| 2 |
Wells Fargo
WFC
|
+$274M |
| 3 |
IBM
IBM
|
+$266M |
| 4 |
Qualcomm
QCOM
|
+$257M |
| 5 |
Mondelez International
MDLZ
|
+$224M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$356M |
| 2 |
PayPal
PYPL
|
+$290M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$261M |
| 4 |
NVIDIA
NVDA
|
+$248M |
| 5 |
AABA
Altaba Inc
AABA
|
+$245M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.31% |
| 2 | Healthcare | 10.66% |
| 3 | Consumer Discretionary | 10.29% |
| 4 | Communication Services | 8.78% |
| 5 | Financials | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PIR
1926
DELISTED
Pier 1 Imports, Inc.
PIR
| $2.15M | ﹤0.01% |
25,652
+5,054
| +25% | +$452K |
|
1927
CALL
Prudential Financial
PRU
$41.5B
| $2.15M | ﹤0.01% |
20,200
| – | – |
|
|
FISV
1928
Fiserv Inc
FISV
$27.9B
| $2.15M | ﹤0.01% |
33,268
-420,774
| -93% | -$26.1M |
|
|
DDC
1929
DELISTED
Dominion Diamond Corporation
DDC
| $2.15M | ﹤0.01% |
151,277
-44,431
| -23% | -$619K |
|
1930
CALL
Diageo
DEO
$52.1B
| $2.14M | ﹤0.01% |
16,200
-50,100
| -76% | -$6.47M |
|
1931
West Pharmaceutical
WST
$24.6B
| $2.14M | ﹤0.01% |
22,236
-108,728
| -83% | -$9.84M |
|
1932
First Interstate BancSystem
FIBK
$3.55B
| $2.14M | ﹤0.01% |
55,926
+24,411
| +77% | +$884K |
|
1933
PUT
HSBC
HSBC
$355B
| $2.13M | ﹤0.01% |
47,279
-32,614
| -41% | -$1.44M |
|
1934
Arthur J. Gallagher & Co
AJG
$67.9B
| $2.13M | ﹤0.01% |
+34,656
| New | +$2.04M |
|
|
DSPG
1935
DELISTED
DSP Group Inc
DSPG
| $2.13M | ﹤0.01% |
163,909
+10,559
| +7% | +$127K |
|
1936
PUT
Moody's
MCO
$89B
| $2.13M | ﹤0.01% |
+15,300
| New | +$2.01M |
|
1937
PUT
EOG Resources
EOG
$76B
| $2.13M | ﹤0.01% |
22,000
+12,500
| +132% | +$1.13M |
|
1938
Haverty Furniture Companies
HVT
$425M
| $2.13M | ﹤0.01% |
81,353
-2,829
| -3% | -$67.6K |
|
1939
Steris
STE
$23.1B
| $2.13M | ﹤0.01% |
24,041
+5,721
| +31% | +$485K |
|
1940
EastGroup Properties
EGP
$10.8B
| $2.12M | ﹤0.01% |
24,090
| – | – |
|
1941
CALL
Regions Financial
RF
$26.2B
| $2.12M | ﹤0.01% |
139,200
-156,100
| -53% | -$2.24M |
|
1942
PUT
CoStar Group
CSGP
$13B
| $2.12M | ﹤0.01% |
+79,000
| New | +$2.19M |
|
1943
Minerals Technologies
MTX
$2.24B
| $2.12M | ﹤0.01% |
29,997
+7,340
| +32% | +$503K |
|
1944
Stoneridge
SRI
$204M
| $2.12M | ﹤0.01% |
106,797
+14,794
| +16% | +$245K |
|
1945
Orion Group Holdings
ORN
$377M
| $2.12M | ﹤0.01% |
322,485
+41,239
| +15% | +$262K |
|
1946
Avient
AVNT
$4.11B
| $2.11M | ﹤0.01% |
52,755
-111,450
| -68% | -$4.16M |
|
1947
Cytokinetics
CYTK
$11B
| $2.11M | ﹤0.01% |
145,666
-58,379
| -29% | -$797K |
|
1948
CALL
Sarepta Therapeutics
SRPT
$2.06B
| $2.11M | ﹤0.01% |
46,500
| – | – |
|
|
WAIR
1949
DELISTED
WESCO Aircraft Holdings Inc.
WAIR
| $2.1M | ﹤0.01% |
223,200
+86,685
| +63% | +$816K |
|
1950
Medpace
MEDP
$17.3B
| $2.1M | ﹤0.01% |
65,692
-8,266
| -11% | -$252K |
|
Similar funds
David Shaw's Q3 2017 Portfolio in Review
As of Q3 2017, David Shaw held 3,794 positions worth $65.1B, up 7.7% from $60.5B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.
David Shaw's Q3 2017 filing shows 469 new, 1,367 increased, 1,237 reduced and 370 closed positions. Its largest new stake was Baker Hughes: 3,076,914 shares worth $113M. The largest sale was Gilead Sciences, an estimated $356M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- David Shaw's largest Q3 2017 buy was Baker Hughes: 3,076,914 shares worth $113M.
- David Shaw added most to Comcast in Q3 2017, an estimated $354M increase.
- David Shaw's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $356M.
- David Shaw fully exited Mobileye N.V. in Q3 2017, selling an estimated $72.4M.
- David Shaw's ten largest holdings make up 9.6% of its $65.1B portfolio in Q3 2017.
- David Shaw opened 469 new positions and closed 370 in Q3 2017.
- David Shaw's portfolio value rose 7.7% quarter-over-quarter to $65.1B.
Based on D.E. Shaw & Co's 13F filing for Q3 2017, filed 14 Nov 2017.